|
Showing 1 - 2 of
2 matches in All Departments
Despite the growing interest in biodiversity as a source of
valuable new products and biochemical information, there have been
very few systematic efforts to estimate the value of preserving
biological resources for this purpose. Drugs of Natural Origin
gives you a detailed model of the value of wild biological
resources for pharmaceutical research and development. Author
Anthony Artuso presents several decision models and analytical
techniques that you can use to assess the economics of biochemical
prospecting efforts whether you re part of a private corporation,
nonprofit research institute, developing country government, or
international organization.Drugs of Natural Origin explores the
policy options available to developing countries and international
organizations to tap into the emerging market for biological
resources in such a way as to provide both incentives for
conservation of biodiversity and new opportunities for economic
development. You ll find evaluations of a range of proactive
strategies that can be used to protect and enhance developing
countries'biological resources. In addition, you ll learn about a
bioeconomic model that incorporates the potential biochemical and
genetic value of a diverse ecosystem into land use planning and
development.Developing country and international policymakers will
find Drugs of Natural Origin a useful tool for determining how best
to conserve biodiversity, while sustainably developing biological
resources. This book outlines a comprehensive and integrated set of
policy measures, research and development initiatives, and
financing arrangements that could increase biochemical research
activity while providing incentives for conservation of
biodiversity and a potential path for sustainable
development.Managers of pharmaceutical R&D programs will use
the decision models developed in Drugs of Natural Origin to plan,
evaluate, and continually refine their R&D programs. The book s
theoretic framework provides you with an analytical tool for
systematically evaluating critical decisions at each stage of the
R&D process. Thus, you learn to incorporate both subjective
assessments and quantitative data into a comprehensive framework
for R&D decisionmaking.
Despite the growing interest in biodiversity as a source of
valuable new products and biochemical information, there have been
very few systematic efforts to estimate the value of preserving
biological resources for this purpose. Drugs of Natural Origin
gives you a detailed model of the value of wild biological
resources for pharmaceutical research and development. Author
Anthony Artuso presents several decision models and analytical
techniques that you can use to assess the economics of biochemical
prospecting efforts whether you?re part of a private corporation,
nonprofit research institute, developing country government, or
international organization.Drugs of Natural Origin explores the
policy options available to developing countries and international
organizations to tap into the emerging market for biological
resources in such a way as to provide both incentives for
conservation of biodiversity and new opportunities for economic
development. You?ll find evaluations of a range of proactive
strategies that can be used to protect and enhance developing
countries'biological resources. In addition, you?ll learn about a
bioeconomic model that incorporates the potential biochemical and
genetic value of a diverse ecosystem into land use planning and
development.Developing country and international policymakers will
find Drugs of Natural Origin a useful tool for determining how best
to conserve biodiversity, while sustainably developing biological
resources. This book outlines a comprehensive and integrated set of
policy measures, research and development initiatives, and
financing arrangements that could increase biochemical research
activity while providing incentives for conservation of
biodiversity and a potential path for sustainable
development.Managers of pharmaceutical R&D programs will use
the decision models developed in Drugs of Natural Origin to plan,
evaluate, and continually refine their R&D programs. The book's
theoretic framework provides you with an analytical tool for
systematically evaluating critical decisions at each stage of the
R&D process. Thus, you learn to incorporate both subjective
assessments and quantitative data into a comprehensive framework
for R&D decisionmaking.
|
|